Correction
The initially published version of the article indicated that “The concept of combining antihypertensives with statins and aspirin for the secondary prevention of CVD was first introduced by the World Health Organization (WHO) in 2001”. In fact, the concept was proposed in 2000 in patents GB 0100548.7 and GB 008791.6 filed by Malcolm Law and Nicholas Wald and discussed in 2001 by a group of experts from WHO and the Wellcome Trust.
Competing Interests
MDH has received travel support from the World Heart Federation. MDH has an appointment at The George Institute for Global Health, which has a patent, license, and has received investment funding with intent to commercialize fixed-dose combination therapy through its social enterprise business, George Medicines. MDH has pending patents for heart failure polypills. Other authors have no competing interests to declare.